Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-786-0 | CAS number: 10361-29-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Test method in accordance with OECD 429 and EU Method B.42. GLP study.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: ELEVAGE JANVIER, Route des Chènes Secs B.P. 4105. 53940 LE GENEST-ST-ISLE, France
- Age at study initiation: 9 weeks old
- Weight at study initiation: 20.0-21.6 grams
- Housing: Group caging. Cage type: Type II. polypropylene / polycarbonate with bedding of certified wood chips
- Diet (e.g. ad libitum): Ad libitum.
- Water (e.g. ad libitum): Ad libitum.
- Acclimation period: 13 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 30 - 70 %
- Air changes (per hr): 15-20 air exchange/hour
- Photoperiod (hrs dark / hrs light): 12 hours daily, from 6.00 a.m. to 6.00 p.m. - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 50, 25 and 10 % w/v test item.
- No. of animals per dose:
- 4 animals per group
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: Based on the observation of the solubility test, the maximum concentration of test item in an acceptable solvent was established at 50 (w/v) % concentration using AOO (acetone:olive oil 4:1 (v:v) mixture).
- Irritation: A Preliminary Irritation/Toxicity Test was performed using 2 mice per dose, at test item concentrations of 50 and 25 (w/v) % in AOO. The preliminary experiment was conducted in a similar experimental manner to the main study, but it was terminated on Day 6. Mice were observed daily for any clinical signs of systemic toxicity or local irritation (scoring according to OECD Guideline 404) and at the application site. Ear thickness was measured using a thickness gauge on Day 1, 3 and 6. No effects were observed, and therefore 50 and 25 (w/v) % doses were considered to be acceptable for the main test.
- Lymph node proliferation response: The radioactive proliferation assay was not performed.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Proliferation assay.
- Criteria used to consider a positive response: The test item is regarded as a sensitizer if both of the following criteria are fulfilled:
That exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than recorded in control mice, as indicated by the stimulation index.
The data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION:
Animals were topically dosed with 25 µL of the appropriate formulation (0, 50, 25 and 10 % w/v) using a pipette on the dorsal surface of each ear. Each animal was dosed once a day for three consecutive days (Days 1, 2 and 3). There was no treatment on Days 4, 5 and 6.
During the study (Day 1 to Day 6) each animal was observed daily for any clinical signs, including local irritation and systemic toxicity. Individual body weights were recorded on Days 1 and 6.
On Day 6, each mouse was intravenously injected via the tail vein with 250 µL of sterile PBS (phosphate buffered saline) containing approximately 20 µCi of 3HTdR. Five hours after mice were euthanized. Then, the draining auricular lymph nodes were excised and the nodes removed. Cell suspension (SCS) of pooled lymph node cells (LNCs) were prepared. After overnight (approximately 18 hours) incubation at 2-8 ºC, the vials were loaded into a β-scintillation counter and 3HTdR incorporation was measured as the number of radioactive disintegrations per minute (DPM) (background level was also measured). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Positive control results:
- No mortality, cutaneous reactions or signs of toxicity were observed for the positive control substance in the study. A significant lymphoproliferative response (stimulation index value of 10.7) was noted for HCA in the main experiment. This value was considered to confirm the appropriate performance of the assay. Furthermore, the DPN values were within the historical control range.
- Parameter:
- SI
- Remarks on result:
- other: Negative (vehicle) control (AOO): 1.0 Ammonium carbonate e 50 (w/v) % in AOO: 1.3 Ammonium carbonate 25 (w/v) % in AOO: 1.7 Ammonium carbonate 10 (w/v) % in AOO: 1.6 Positive control (25 (w/v) % HCA in AOO): 10.7
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Negative (vehicle) control (AOO): 1131.5 Ammonium carbonate 50 (w/v) % in AOO: 1516.5 Ammonium carbonate 25 (w/v) % in AOO: 1922.5 Ammonium carbonate 10 (w/v) % in AOO: 1787.5 Positive control (25 (w/v) % HCA in AOO): 12132.5
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Ammonium carbonate was shown to have no sensitization potential (non-sensitizer) in the Local Lymph Node Assay. The observed stimulation index values were 1.3, 1.7 and 1.6 at concentrations of 50, 25 and 10 (w/v) %, respectively.
- Executive summary:
A skin sensitization Local Lymph Node Assay was performed on Ammonium carbonate in accordance with OECD Guideline 429 and EU method B.42. Based on the preliminary compatibility test the highest achievable concentrations was 50 (w/v) % in AOO (acetone: olive oil 4:1 (v:v) mixture) as vehicle. No effects were observed in the preliminary irritation/toxicity test at 50 and 25% (w/v) % in AOO. In the main assay, 4 female mice per dose were dermally exposed to 25 µL/ear application of 0 (vehicle control), 50, 25, 10 (w/v) % Ammonium carbonate , 25 (w/v) % HCA (positive control) for 3 consecutive days. There was no treatment for another 3 consecutive days. On Day 6, the cell proliferation in the local lymph nodes was measured by incorporation of tritiated methyl thymidine (3HTdR) and the values obtained were used to calculate stimulation indices (SI). No mortality or systemic clinical signs were observed during the study. No treatment related effects were observed on animal body weights in any treated groups. There were no indications of any irritancy at the site of application. The observed stimulation index values were 1.3, 1.7 and 1.6 at concentrations of 50, 25 and 10 (w/v) %, respectively. All the validity criteria were fulfilled. In conclusion, under the conditions of the present assay Ammonium carbonate , tested in a suitable vehicle, was shown to have no sensitisation potential (non-sensitizer) in the Local Lymph Node Assay.
Reference
No mortality or signs of systemic toxicity were observed during the study. There were no indications of any irritancy at the site of application. No treatment related effects were observed on animal body weights.
DPM, DPN and Stimulation Index Values for all Groups:
Test Group Name |
Measured DPM / group |
DPM |
Number |
DPN |
Stimulation Index |
Background |
36.5 |
- |
- |
- |
- |
(5 (w/v) % TCA) |
|||||
Negative (vehicle) control |
1168 |
1131.5 |
8 |
141.4 |
1.0 |
(AOO) |
|||||
Ammonium carbonate |
1553 |
1516.5 |
8 |
189.6 |
1.3 |
50 (w/v) % in AOO |
|||||
Ammonium carbonate |
1959 |
1922.5 |
8 |
240.3 |
1.7 |
25 (w/v) % in AOO |
|||||
Ammonium carbonate |
1824 |
1787.5 |
8 |
223.4 |
1.6 |
10 (w/v) % in AOO |
|||||
Positive control |
12169 |
12132.5 |
8 |
1516.6 |
10.7 |
(25 (w/v) % HCA in AOO) |
All validity criteria were fulfilled.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
- Migrated from Short description of key information:
Ammonium carbonate was shown to have no sensitization potential (non-sensitizer) in the Local Lymph Node Assay. The observed stimulation index values were 1.3, 1.7 and 1.6 at concentrations of 50, 25 and 10 (w/v) %, respectively.
Justification for classification or non-classification
The substance is not classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.